Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 3
1988 2
1989 2
1990 5
1991 4
1992 4
1993 4
1994 3
1995 2
1996 5
1997 4
1998 1
1999 2
2000 2
2001 4
2002 9
2003 3
2005 4
2006 2
2007 4
2008 1
2011 2
2012 2
2013 3
2014 4
2015 2
2016 1
2017 3
2018 3
2019 3
2020 4
2021 1
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Gauvreau GM, Hohlfeld JM, FitzGerald JM, Boulet LP, Cockcroft DW, Davis BE, Korn S, Kornmann O, Leigh R, Mayers I, Watz H, Grant SS, Jain M, Cabanski M, Pertel PE, Jones I, Lecot JR, Cao H, O'Byrne PM. Gauvreau GM, et al. Among authors: mayers i. Eur Respir J. 2023 Mar 9;61(3):2201193. doi: 10.1183/13993003.01193-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36822634 Free PMC article. Clinical Trial.
Multidisciplinary Inflammatory Airway Team Experience.
O'Brien DC, Bhutani M, Vliagoftis H, Leung W, Cote D, Mayers I, Yehya J, Wright ED. O'Brien DC, et al. Among authors: mayers i. J Allergy Clin Immunol Pract. 2022 Apr;10(4):1123. doi: 10.1016/j.jaip.2022.01.022. J Allergy Clin Immunol Pract. 2022. PMID: 35397809 No abstract available.
Impact of Undiagnosed Chronic Obstructive Pulmonary Disease and Asthma on Symptoms, Quality of Life, Healthcare Use, and Work Productivity.
Gerstein E, Bierbrier J, Whitmore GA, Vandemheen KL, Bergeron C, Boulet LP, Cote A, Field SK, Penz E, McIvor RA, Lemière C, Gupta S, Hernandez P, Mayers I, Bhutani M, Lougheed MD, Licskai CJ, Azher T, Ezer N, Ainslie M, Alvarez GG, Mulpuru S, Aaron SD. Gerstein E, et al. Among authors: mayers i. Am J Respir Crit Care Med. 2023 Dec 15;208(12):1271-1282. doi: 10.1164/rccm.202307-1264OC. Am J Respir Crit Care Med. 2023. PMID: 37792953
Cost-effectiveness of tezepelumab in Canada for severe asthma.
Habash M, Guiang H, Mayers I, Quinton A, Vuong V, Dineen A, Singh S, Gibson D, Turner AP. Habash M, et al. Among authors: mayers i. J Med Econ. 2023 Jan-Dec;26(1):902-914. doi: 10.1080/13696998.2023.2234235. J Med Econ. 2023. PMID: 37417781 Free article.
Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
Alhabeeb FF, Whitmore GA, Vandemheen KL, FitzGerald JM, Bergeron C, Lemière C, Boulet LP, Field SK, Penz E, McIvor RA, Gupta S, Mayers I, Bhutani M, Hernandez P, Lougheed D, Licskai CJ, Azher T, Cote A, Ainslie M, Fraser I, Mahdavian M, Aaron SD. Alhabeeb FF, et al. Among authors: mayers i. Respir Med. 2022 Aug-Sep;200:106917. doi: 10.1016/j.rmed.2022.106917. Epub 2022 Jul 3. Respir Med. 2022. PMID: 35850008
106 results